37 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 33977560 | α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders. | 2021 Jul | 1 | ||
2 | 31096265 | The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans. | 2020 May 26 | 1 | ||
3 | 27805736 | Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells. | 2017 Jan | 3 | ||
4 | 28268112 | Taking varenicline for smoking cessation: A rare cause of pulmonary thromboembolism with infarction. | 2017 Jul | 7 | ||
5 | 28842382 | Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis. | 2017 Sep 1 | 1 | ||
6 | 29196725 | Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies. | 2017 Dec 1 | 1 | ||
7 | 27028298 | Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake. | 2016 | 3 | ||
8 | 27613505 | Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia. | 2016 Dec | 1 | ||
9 | 25475645 | Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. | 2015 Feb | 2 | ||
10 | 25774163 | CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy. | 2015 | 2 | ||
11 | 24406270 | Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control. | 2014 Jun | 1 | ||
12 | 24627467 | Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors. | 2014 May | 2 | ||
13 | 24628360 | Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens. | 2014 Jul | 2 | ||
14 | 24836728 | Role for the nicotinic cholinergic system in movement disorders; therapeutic implications. | 2014 Oct | 1 | ||
15 | 25581658 | Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization. | 2014 Dec | 2 | ||
16 | 23042213 | Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. | 2013 | 1 | ||
17 | 23110878 | Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers. | 2013 Feb 1 | 2 | ||
18 | 23641218 | Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. | 2013 | 1 | ||
19 | 23801676 | PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics. | 2013 Aug | 1 | ||
20 | 22048466 | Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. | 2012 Feb | 1 | ||
21 | 22395733 | A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain. | 2012 Jun | 2 | ||
22 | 22547331 | Varenicline decreases alcohol consumption in heavy-drinking smokers. | 2012 Oct | 2 | ||
23 | 21097981 | Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. | 2011 Jan | 1 | ||
24 | 21368748 | Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons. | 2011 Jun | 1 | ||
25 | 19959340 | The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. | 2010 Feb | 3 | ||
26 | 20167427 | Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain. | 2010 Apr | 1 | ||
27 | 20331614 | Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. | 2010 May | 1 | ||
28 | 20373480 | Varenicline does not increase serum BDNF levels in patients with nicotine dependence. | 2010 Apr | 2 | ||
29 | 20946306 | The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. | 2010 Dec | 3 | ||
30 | 19501054 | Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. | 2009 Oct 1 | 3 | ||
31 | 19693492 | Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. | 2009 Nov | 2 | ||
32 | 20071853 | Varenicline: for smoking cessation. | 2009 Apr-Jun | 2 | ||
33 | 18342165 | Efficacy and safety of varenicline for smoking cessation. | 2008 Apr | 2 | ||
34 | 20040957 | Partial nicotinic acetylcholine (alpha4beta2) agonists as promising new medications for smoking cessation. | 2008 Oct | 1 | ||
35 | 23506178 | The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions. | 2008 Sep | 1 | ||
36 | 17353944 | Varenicline: new treatment with efficacy in smoking cessation. | 2007 Feb | 3 | ||
37 | 15887955 | Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. | 2005 May 19 | 1 |